<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[PPD 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=24653></link><description><![CDATA[PPD 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 03:24:06 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2015/04/3554153577_20150409113937_5432660012.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[PPD and SNBL Complete Joint Venture to Provide Japanese Clinical Development Services and Additional Collaborations]]></title><link>https://www.newswire.co.kr/newsRead.php?no=788364</link><description><![CDATA[WILMINGTON, N.C. & TOKYO--(Business Wire/Korea Newswire)--Pharmaceutical Product Development, LLC (PPD, ) and Shin Nippon Biomedical Laboratories Ltd. (SNBL, ) (TSE:2395) today announced the closing of an agreement to form a joint venture to provide clinical development services  in Japan.  With the completion of the deal, PPD-SNBL is one of the largest clinical development service providers in Japan, ...]]></description><pubDate>Thu, 09 Apr 2015 11:45:00 +0900</pubDate></item><item><title><![CDATA[PPD, SNBL과 합작사 설립 매듭…일본 내 임상개발 서비스 지원 및 추가 협력 도모]]></title><link>https://www.newswire.co.kr/newsRead.php?no=788366</link><description><![CDATA[윌밍턴, 노스캐롤라이나 및 도쿄--(Business Wire/뉴스와이어)--파마슈티컬 프러덕트 디벨로프먼트(Pharmaceutical Product Development, LLC)(이하 PPD, )와 신일본과학(Shin Nippon Biomedical Laboratories Ltd.)(이하 SNBL, )(도쿄증권거래소: 2395)이 일본 내 임상개발 서비스(clinical development services, )를 지원할 합작사 설립 계약을 최종 매듭지었다고 오늘 발표했다.  계약 완료와 더불어 PPD-SNBL은 일본 최대의 임상개발...]]></description><pubDate>Thu, 09 Apr 2015 11:45:00 +0900</pubDate></item></channel></rss>